APO Research
Talk to an analyst

APO RESEARCH · REPORT

E. coli Competent Cells

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global E. coli Competent Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025198 pages

Choose your research edition.

Industry ResearchE. coli Competent Cells Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal E. coli Competent Cells Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal E. coli Competent Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal E. coli Competent Cells Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal E. coli Competent Cells Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global E. coli Competent Cells market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for E. coli Competent Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for E. coli Competent Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for E. coli Competent Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for E. coli Competent Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of E. coli Competent Cells include Addgene, Agilent, Beijing TransGen Biotech, Bioline, Bio-Rad, GCC Biotech, GenScript, IBA and LGC Biosearch Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global E. coli Competent Cells market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of E. coli Competent Cells and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents E. coli Competent Cells sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the E. coli Competent Cells market size, projected growth trends, production technologies, key applications, and end-use industries.

E. coli Competent Cells Segment by Company

Addgene

Agilent

Beijing TransGen Biotech

Bioline

Bio-Rad

GCC Biotech

GenScript

IBA

LGC Biosearch Technologies

New England Biolabs

New England Biolabs (NEB)

Promega Corporation

QIAGEN

Scarab Genomics

Takara Bio

Zymo Research

Beyotime

Maokangbio

Merck

Thermo Fisher Scientific

TIANGEN

NCM Biotech

Yeasen

ZOMANBIO

E. coli Competent Cells Segment by Type

Chemically Competent Cells

Electrocompetent Cells

E. coli Competent Cells Segment by Application

Cloning

Proteomics

Genomics

E. coli Competent Cells Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global E. coli Competent Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of E. coli Competent Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of E. coli Competent Cells.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the E. coli Competent Cells market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of E. coli Competent Cells manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of E. coli Competent Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of E. coli Competent Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. E. coli Competent Cells Industry Trends Table 2. E. coli Competent Cells Industry Drivers Table 3. E. coli Competent Cells Industry Opportunities and Challenges Table 4. E. coli Competent Cells Industry Restraints Table 5. Global E. coli Competent Cells Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global E. coli Competent Cells Revenue Market Share by Manufacturers (2021-2026) Table 7. Global E. coli Competent Cells Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global E. coli Competent Cells Sales Market Share by Manufacturers Table 9. Global E. coli Competent Cells Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global E. coli Competent Cells Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global E. coli Competent Cells Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global E. coli Competent Cells Manufacturers, Product Type & Application Table 13. Global E. coli Competent Cells Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global E. coli Competent Cells by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Chemically Competent Cells Table 17. Major Manufacturers of Electrocompetent Cells Table 18. Global E. coli Competent Cells Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global E. coli Competent Cells Sales by Type (2021-2026) & (K Units) Table 20. Global E. coli Competent Cells Sales by Type (2027-2032) & (K Units) Table 21. Global E. coli Competent Cells Sales Market Share by Type (2021-2026) Table 22. Global E. coli Competent Cells Sales Market Share by Type (2027-2032) Table 23. Global E. coli Competent Cells Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global E. coli Competent Cells Revenue by Type (2021-2026) & (K Units) Table 25. Global E. coli Competent Cells Revenue by Type (2027-2032) & (K Units) Table 26. Global E. coli Competent Cells Revenue Market Share by Type (2021-2026) Table 27. Global E. coli Competent Cells Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Cloning Table 29. Major Manufacturers of Proteomics Table 30. Major Manufacturers of Genomics Table 31. Global E. coli Competent Cells Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global E. coli Competent Cells Sales by Application (2021-2026) & (K Units) Table 33. Global E. coli Competent Cells Sales by Application (2027-2032) & (K Units) Table 34. Global E. coli Competent Cells Sales Market Share by Application (2021-2026) Table 35. Global E. coli Competent Cells Sales Market Share by Application (2027-2032) Table 36. Global E. coli Competent Cells Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global E. coli Competent Cells Revenue by Application (2021-2026) & (K Units) Table 38. Global E. coli Competent Cells Revenue by Application (2027-2032) & (K Units) Table 39. Global E. coli Competent Cells Revenue Market Share by Application (2021-2026) Table 40. Global E. coli Competent Cells Revenue Market Share by Application (2027-2032) Table 41. Global E. coli Competent Cells Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global E. coli Competent Cells Sales by Region (2021-2026) & (K Units) Table 43. Global E. coli Competent Cells Sales Market Share by Region (2021-2026) Table 44. Global E. coli Competent Cells Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global E. coli Competent Cells Sales Forecasted Market Share by Region (2027-2032) Table 46. North America E. coli Competent Cells Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America E. coli Competent Cells Sales by Country (2021-2026) & (K Units) Table 48. North America E. coli Competent Cells Sales by Country (2027-2032) & (K Units) Table 49. Europe E. coli Competent Cells Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe E. coli Competent Cells Sales by Country (2021-2026) & (K Units) Table 51. Europe E. coli Competent Cells Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific E. coli Competent Cells Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific E. coli Competent Cells Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific E. coli Competent Cells Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa E. coli Competent Cells Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa E. coli Competent Cells Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa E. coli Competent Cells Sales by Country (2027-2032) & (K Units) Table 58. Global E. coli Competent Cells Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global E. coli Competent Cells Revenue by Region (2021-2026) & (US$ Million) Table 60. Global E. coli Competent Cells Revenue by Region (2027-2032) & (US$ Million) Table 61. Global E. coli Competent Cells Revenue Market Share by Region (2021-2026) Table 62. Global E. coli Competent Cells Revenue Market Share by Region (2027-2032) Table 63. Addgene Company Information Table 64. Addgene Business Overview Table 65. Addgene E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Addgene E. coli Competent Cells Product Portfolio Table 67. Addgene Recent Development Table 68. Agilent Company Information Table 69. Agilent Business Overview Table 70. Agilent E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Agilent E. coli Competent Cells Product Portfolio Table 72. Agilent Recent Development Table 73. Beijing TransGen Biotech Company Information Table 74. Beijing TransGen Biotech Business Overview Table 75. Beijing TransGen Biotech E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Beijing TransGen Biotech E. coli Competent Cells Product Portfolio Table 77. Beijing TransGen Biotech Recent Development Table 78. Bioline Company Information Table 79. Bioline Business Overview Table 80. Bioline E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Bioline E. coli Competent Cells Product Portfolio Table 82. Bioline Recent Development Table 83. Bio-Rad Company Information Table 84. Bio-Rad Business Overview Table 85. Bio-Rad E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Bio-Rad E. coli Competent Cells Product Portfolio Table 87. Bio-Rad Recent Development Table 88. GCC Biotech Company Information Table 89. GCC Biotech Business Overview Table 90. GCC Biotech E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. GCC Biotech E. coli Competent Cells Product Portfolio Table 92. GCC Biotech Recent Development Table 93. GenScript Company Information Table 94. GenScript Business Overview Table 95. GenScript E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. GenScript E. coli Competent Cells Product Portfolio Table 97. GenScript Recent Development Table 98. IBA Company Information Table 99. IBA Business Overview Table 100. IBA E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. IBA E. coli Competent Cells Product Portfolio Table 102. IBA Recent Development Table 103. LGC Biosearch Technologies Company Information Table 104. LGC Biosearch Technologies Business Overview Table 105. LGC Biosearch Technologies E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. LGC Biosearch Technologies E. coli Competent Cells Product Portfolio Table 107. LGC Biosearch Technologies Recent Development Table 108. New England Biolabs Company Information Table 109. New England Biolabs Business Overview Table 110. New England Biolabs E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. New England Biolabs E. coli Competent Cells Product Portfolio Table 112. New England Biolabs Recent Development Table 113. New England Biolabs (NEB) Company Information Table 114. New England Biolabs (NEB) Business Overview Table 115. New England Biolabs (NEB) E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. New England Biolabs (NEB) E. coli Competent Cells Product Portfolio Table 117. New England Biolabs (NEB) Recent Development Table 118. Promega Corporation Company Information Table 119. Promega Corporation Business Overview Table 120. Promega Corporation E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Promega Corporation E. coli Competent Cells Product Portfolio Table 122. Promega Corporation Recent Development Table 123. QIAGEN Company Information Table 124. QIAGEN Business Overview Table 125. QIAGEN E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. QIAGEN E. coli Competent Cells Product Portfolio Table 127. QIAGEN Recent Development Table 128. Scarab Genomics Company Information Table 129. Scarab Genomics Business Overview Table 130. Scarab Genomics E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Scarab Genomics E. coli Competent Cells Product Portfolio Table 132. Scarab Genomics Recent Development Table 133. Takara Bio Company Information Table 134. Takara Bio Business Overview Table 135. Takara Bio E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Takara Bio E. coli Competent Cells Product Portfolio Table 137. Takara Bio Recent Development Table 138. Zymo Research Company Information Table 139. Zymo Research Business Overview Table 140. Zymo Research E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Zymo Research E. coli Competent Cells Product Portfolio Table 142. Zymo Research Recent Development Table 143. Beyotime Company Information Table 144. Beyotime Business Overview Table 145. Beyotime E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Beyotime E. coli Competent Cells Product Portfolio Table 147. Beyotime Recent Development Table 148. Maokangbio Company Information Table 149. Maokangbio Business Overview Table 150. Maokangbio E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Maokangbio E. coli Competent Cells Product Portfolio Table 152. Maokangbio Recent Development Table 153. Merck Company Information Table 154. Merck Business Overview Table 155. Merck E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Merck E. coli Competent Cells Product Portfolio Table 157. Merck Recent Development Table 158. Thermo Fisher Scientific Company Information Table 159. Thermo Fisher Scientific Business Overview Table 160. Thermo Fisher Scientific E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Thermo Fisher Scientific E. coli Competent Cells Product Portfolio Table 162. Thermo Fisher Scientific Recent Development Table 163. TIANGEN Company Information Table 164. TIANGEN Business Overview Table 165. TIANGEN E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. TIANGEN E. coli Competent Cells Product Portfolio Table 167. TIANGEN Recent Development Table 168. NCM Biotech Company Information Table 169. NCM Biotech Business Overview Table 170. NCM Biotech E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 171. NCM Biotech E. coli Competent Cells Product Portfolio Table 172. NCM Biotech Recent Development Table 173. Yeasen Company Information Table 174. Yeasen Business Overview Table 175. Yeasen E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 176. Yeasen E. coli Competent Cells Product Portfolio Table 177. Yeasen Recent Development Table 178. ZOMANBIO Company Information Table 179. ZOMANBIO Business Overview Table 180. ZOMANBIO E. coli Competent Cells Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 181. ZOMANBIO E. coli Competent Cells Product Portfolio Table 182. ZOMANBIO Recent Development Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. E. coli Competent Cells Distributors List Table 186. E. coli Competent Cells Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. E. coli Competent Cells Product Image Figure 2. Global E. coli Competent Cells Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global E. coli Competent Cells Market Size (2021-2032) & (US$ Million) Figure 4. Global E. coli Competent Cells Sales (2021-2032) & (K Units) Figure 5. Global E. coli Competent Cells Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 E. coli Competent Cells Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Chemically Competent Cells Image Figure 9. Electrocompetent Cells Image Figure 10. Global E. coli Competent Cells Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global E. coli Competent Cells Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global E. coli Competent Cells Sales Market Share by Type (2021-2032) Figure 13. Global E. coli Competent Cells Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global E. coli Competent Cells Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global E. coli Competent Cells Revenue Market Share by Type (2021-2032) Figure 16. Cloning Image Figure 17. Proteomics Image Figure 18. Genomics Image Figure 19. Global E. coli Competent Cells Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global E. coli Competent Cells Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global E. coli Competent Cells Sales Market Share by Application (2021-2032) Figure 22. Global E. coli Competent Cells Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global E. coli Competent Cells Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global E. coli Competent Cells Revenue Market Share by Application (2021-2032) Figure 25. North America E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America E. coli Competent Cells Sales Market Share by Country (2021-2032) Figure 27. U.S. E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe E. coli Competent Cells Sales Market Share by Country (2021-2032) Figure 32. Germany E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific E. coli Competent Cells Sales Market Share by Country (2021-2032) Figure 39. China E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa E. coli Competent Cells Sales Market Share by Country (2021-2032) Figure 47. Brazil E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile E. coli Competent Cells Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global E. coli Competent Cells Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global E. coli Competent Cells Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Figure 58. North America E. coli Competent Cells Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Figure 60. Europe E. coli Competent Cells Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific E. coli Competent Cells Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa E. coli Competent Cells Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. E. coli Competent Cells Value Chain Figure 66. Manufacturing Cost Structure Figure 67. E. coli Competent Cells Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Chemically Competent Cells
  • Electrocompetent Cells
Applications
  • Cloning
  • Proteomics
  • Genomics
Companies covered
  • Addgene
  • Agilent
  • Beijing TransGen Biotech
  • Bioline
  • Bio-Rad
  • GCC Biotech
  • GenScript
  • IBA
  • LGC Biosearch Technologies
  • New England Biolabs
  • New England Biolabs (NEB)
  • Promega Corporation
  • QIAGEN
  • Scarab Genomics
  • Takara Bio
  • Zymo Research
  • Beyotime
  • Maokangbio
  • Merck
  • Thermo Fisher Scientific
  • TIANGEN
  • NCM Biotech
  • Yeasen
  • ZOMANBIO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global E. coli Competent Cells Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global E. coli Competent Cells Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global E. coli Competent Cells Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global E. coli Competent Cells Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global E. coli Competent Cells Market Dynamics
  1. 2.1 E. coli Competent Cells Industry Trends
  2. 2.2 E. coli Competent Cells Industry Drivers
  3. 2.3 E. coli Competent Cells Industry Opportunities and Challenges
  4. 2.4 E. coli Competent Cells Industry Restraints
3 E. coli Competent Cells Market by Manufacturers
  1. 3.1 Global E. coli Competent Cells Revenue by Manufacturers (2021-2026)
  2. 3.2 Global E. coli Competent Cells Sales by Manufacturers (2021-2026)
  3. 3.3 Global E. coli Competent Cells Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global E. coli Competent Cells Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global E. coli Competent Cells Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global E. coli Competent Cells Manufacturers, Product Type & Application
  7. 3.7 Global E. coli Competent Cells Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global E. coli Competent Cells Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 E. coli Competent Cells Players Market Share by Revenue in 2025
  11. 3.8.3 2025 E. coli Competent Cells Tier 1, Tier 2, and Tier 3
4 E. coli Competent Cells Market by Type
  1. 4.1 E. coli Competent Cells Type Introduction
  2. 4.1.1 Chemically Competent Cells
  3. 4.1.2 Electrocompetent Cells
  4. 4.2 Global E. coli Competent Cells Sales by Type
  5. 4.2.1 Global E. coli Competent Cells Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global E. coli Competent Cells Sales by Type (2021-2032)
  7. 4.2.3 Global E. coli Competent Cells Sales Market Share by Type (2021-2032)
  8. 4.3 Global E. coli Competent Cells Revenue by Type
  9. 4.3.1 Global E. coli Competent Cells Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global E. coli Competent Cells Revenue by Type (2021-2032)
  11. 4.3.3 Global E. coli Competent Cells Revenue Market Share by Type (2021-2032)
5 E. coli Competent Cells Market by Application
  1. 5.1 E. coli Competent Cells Application Introduction
  2. 5.1.1 Cloning
  3. 5.1.2 Proteomics
  4. 5.1.3 Genomics
  5. 5.2 Global E. coli Competent Cells Sales by Application
  6. 5.2.1 Global E. coli Competent Cells Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global E. coli Competent Cells Sales by Application (2021-2032)
  8. 5.2.3 Global E. coli Competent Cells Sales Market Share by Application (2021-2032)
  9. 5.3 Global E. coli Competent Cells Revenue by Application
  10. 5.3.1 Global E. coli Competent Cells Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global E. coli Competent Cells Revenue by Application (2021-2032)
  12. 5.3.3 Global E. coli Competent Cells Revenue Market Share by Application (2021-2032)
6 Global E. coli Competent Cells Sales by Region
  1. 6.1 Global E. coli Competent Cells Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global E. coli Competent Cells Sales by Region (2021-2032)
  3. 6.2.1 Global E. coli Competent Cells Sales by Region (2021-2026)
  4. 6.2.2 Global E. coli Competent Cells Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America E. coli Competent Cells Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America E. coli Competent Cells Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe E. coli Competent Cells Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe E. coli Competent Cells Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific E. coli Competent Cells Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific E. coli Competent Cells Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa E. coli Competent Cells Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa E. coli Competent Cells Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global E. coli Competent Cells Revenue by Region
  1. 7.1 Global E. coli Competent Cells Revenue by Region
  2. 7.1.1 Global E. coli Competent Cells Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global E. coli Competent Cells Revenue by Region (2021-2026)
  4. 7.1.3 Global E. coli Competent Cells Revenue by Region (2027-2032)
  5. 7.1.4 Global E. coli Competent Cells Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America E. coli Competent Cells Revenue (2021-2032)
  8. 7.2.2 North America E. coli Competent Cells Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe E. coli Competent Cells Revenue (2021-2032)
  11. 7.3.2 Europe E. coli Competent Cells Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific E. coli Competent Cells Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific E. coli Competent Cells Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa E. coli Competent Cells Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa E. coli Competent Cells Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Addgene
  2. 8.1.1 Addgene Company Information
  3. 8.1.2 Addgene Business Overview
  4. 8.1.3 Addgene E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Addgene E. coli Competent Cells Product Portfolio
  6. 8.1.5 Addgene Recent Developments
  7. 8.2 Agilent
  8. 8.2.1 Agilent Company Information
  9. 8.2.2 Agilent Business Overview
  10. 8.2.3 Agilent E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Agilent E. coli Competent Cells Product Portfolio
  12. 8.2.5 Agilent Recent Developments
  13. 8.3 Beijing TransGen Biotech
  14. 8.3.1 Beijing TransGen Biotech Company Information
  15. 8.3.2 Beijing TransGen Biotech Business Overview
  16. 8.3.3 Beijing TransGen Biotech E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Beijing TransGen Biotech E. coli Competent Cells Product Portfolio
  18. 8.3.5 Beijing TransGen Biotech Recent Developments
  19. 8.4 Bioline
  20. 8.4.1 Bioline Company Information
  21. 8.4.2 Bioline Business Overview
  22. 8.4.3 Bioline E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bioline E. coli Competent Cells Product Portfolio
  24. 8.4.5 Bioline Recent Developments
  25. 8.5 Bio-Rad
  26. 8.5.1 Bio-Rad Company Information
  27. 8.5.2 Bio-Rad Business Overview
  28. 8.5.3 Bio-Rad E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bio-Rad E. coli Competent Cells Product Portfolio
  30. 8.5.5 Bio-Rad Recent Developments
  31. 8.6 GCC Biotech
  32. 8.6.1 GCC Biotech Company Information
  33. 8.6.2 GCC Biotech Business Overview
  34. 8.6.3 GCC Biotech E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GCC Biotech E. coli Competent Cells Product Portfolio
  36. 8.6.5 GCC Biotech Recent Developments
  37. 8.7 GenScript
  38. 8.7.1 GenScript Company Information
  39. 8.7.2 GenScript Business Overview
  40. 8.7.3 GenScript E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GenScript E. coli Competent Cells Product Portfolio
  42. 8.7.5 GenScript Recent Developments
  43. 8.8 IBA
  44. 8.8.1 IBA Company Information
  45. 8.8.2 IBA Business Overview
  46. 8.8.3 IBA E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 IBA E. coli Competent Cells Product Portfolio
  48. 8.8.5 IBA Recent Developments
  49. 8.9 LGC Biosearch Technologies
  50. 8.9.1 LGC Biosearch Technologies Company Information
  51. 8.9.2 LGC Biosearch Technologies Business Overview
  52. 8.9.3 LGC Biosearch Technologies E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 LGC Biosearch Technologies E. coli Competent Cells Product Portfolio
  54. 8.9.5 LGC Biosearch Technologies Recent Developments
  55. 8.10 New England Biolabs
  56. 8.10.1 New England Biolabs Company Information
  57. 8.10.2 New England Biolabs Business Overview
  58. 8.10.3 New England Biolabs E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 New England Biolabs E. coli Competent Cells Product Portfolio
  60. 8.10.5 New England Biolabs Recent Developments
  61. 8.11 New England Biolabs (NEB)
  62. 8.11.1 New England Biolabs (NEB) Company Information
  63. 8.11.2 New England Biolabs (NEB) Business Overview
  64. 8.11.3 New England Biolabs (NEB) E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 New England Biolabs (NEB) E. coli Competent Cells Product Portfolio
  66. 8.11.5 New England Biolabs (NEB) Recent Developments
  67. 8.12 Promega Corporation
  68. 8.12.1 Promega Corporation Company Information
  69. 8.12.2 Promega Corporation Business Overview
  70. 8.12.3 Promega Corporation E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Promega Corporation E. coli Competent Cells Product Portfolio
  72. 8.12.5 Promega Corporation Recent Developments
  73. 8.13 QIAGEN
  74. 8.13.1 QIAGEN Company Information
  75. 8.13.2 QIAGEN Business Overview
  76. 8.13.3 QIAGEN E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 QIAGEN E. coli Competent Cells Product Portfolio
  78. 8.13.5 QIAGEN Recent Developments
  79. 8.14 Scarab Genomics
  80. 8.14.1 Scarab Genomics Company Information
  81. 8.14.2 Scarab Genomics Business Overview
  82. 8.14.3 Scarab Genomics E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Scarab Genomics E. coli Competent Cells Product Portfolio
  84. 8.14.5 Scarab Genomics Recent Developments
  85. 8.15 Takara Bio
  86. 8.15.1 Takara Bio Company Information
  87. 8.15.2 Takara Bio Business Overview
  88. 8.15.3 Takara Bio E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Takara Bio E. coli Competent Cells Product Portfolio
  90. 8.15.5 Takara Bio Recent Developments
  91. 8.16 Zymo Research
  92. 8.16.1 Zymo Research Company Information
  93. 8.16.2 Zymo Research Business Overview
  94. 8.16.3 Zymo Research E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Zymo Research E. coli Competent Cells Product Portfolio
  96. 8.16.5 Zymo Research Recent Developments
  97. 8.17 Beyotime
  98. 8.17.1 Beyotime Company Information
  99. 8.17.2 Beyotime Business Overview
  100. 8.17.3 Beyotime E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Beyotime E. coli Competent Cells Product Portfolio
  102. 8.17.5 Beyotime Recent Developments
  103. 8.18 Maokangbio
  104. 8.18.1 Maokangbio Company Information
  105. 8.18.2 Maokangbio Business Overview
  106. 8.18.3 Maokangbio E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Maokangbio E. coli Competent Cells Product Portfolio
  108. 8.18.5 Maokangbio Recent Developments
  109. 8.19 Merck
  110. 8.19.1 Merck Company Information
  111. 8.19.2 Merck Business Overview
  112. 8.19.3 Merck E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Merck E. coli Competent Cells Product Portfolio
  114. 8.19.5 Merck Recent Developments
  115. 8.20 Thermo Fisher Scientific
  116. 8.20.1 Thermo Fisher Scientific Company Information
  117. 8.20.2 Thermo Fisher Scientific Business Overview
  118. 8.20.3 Thermo Fisher Scientific E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Thermo Fisher Scientific E. coli Competent Cells Product Portfolio
  120. 8.20.5 Thermo Fisher Scientific Recent Developments
  121. 8.21 TIANGEN
  122. 8.21.1 TIANGEN Company Information
  123. 8.21.2 TIANGEN Business Overview
  124. 8.21.3 TIANGEN E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 TIANGEN E. coli Competent Cells Product Portfolio
  126. 8.21.5 TIANGEN Recent Developments
  127. 8.22 NCM Biotech
  128. 8.22.1 NCM Biotech Company Information
  129. 8.22.2 NCM Biotech Business Overview
  130. 8.22.3 NCM Biotech E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 NCM Biotech E. coli Competent Cells Product Portfolio
  132. 8.22.5 NCM Biotech Recent Developments
  133. 8.23 Yeasen
  134. 8.23.1 Yeasen Company Information
  135. 8.23.2 Yeasen Business Overview
  136. 8.23.3 Yeasen E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Yeasen E. coli Competent Cells Product Portfolio
  138. 8.23.5 Yeasen Recent Developments
  139. 8.24 ZOMANBIO
  140. 8.24.1 ZOMANBIO Company Information
  141. 8.24.2 ZOMANBIO Business Overview
  142. 8.24.3 ZOMANBIO E. coli Competent Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 ZOMANBIO E. coli Competent Cells Product Portfolio
  144. 8.24.5 ZOMANBIO Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 E. coli Competent Cells Value Chain Analysis
  2. 9.1.1 E. coli Competent Cells Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 E. coli Competent Cells Production Mode & Process
  6. 9.2 E. coli Competent Cells Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 E. coli Competent Cells Distributors
  9. 9.2.3 E. coli Competent Cells Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst